Medical Devices
-
Roche plans $550M expansion of Indianapolis site to manufacture CGMs
Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its sensors.
By Elise Reuter • May 12, 2025 -
US, China agree to reduce tariff rates for 90 days
By Wednesday, the two countries will charge 10% baseline duties during the period and remove certain retaliatory levies that pushed rates over 100%.
By Philip Neuffer • May 12, 2025 -
Explore the Trendline➔
Sitthiphong via Getty ImagesTrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Earnings & Tariffs
Solventum’s projected $100M tariff hit prevents earnings increase
CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its supply chains.
By Nick Paul Taylor • May 12, 2025 -
New Insulet CEO Ashley McEvoy sets priorities
The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.
By Elise Reuter • May 9, 2025 -
SEC ends probe of Illumina’s Grail acquisition
The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.
By Susan Kelly • May 9, 2025 -
FDA, aiming to speed scientific reviews, names chief AI officer
Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA scientists spend less time on repetitive tasks.
By Susan Kelly • May 9, 2025 -
Q&A
ADA’s Osagie Ebekozien on diabetes tech for Type 2, new CGM standards
Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices authorized for Type 2 diabetes.
By Elise Reuter • May 9, 2025 -
Bausch + Lomb receives CE mark for Luxlife intraocular lens
The company plans to launch the lens, which supports vision at all distances, in Europe in the coming weeks.
By Nick Paul Taylor • May 9, 2025 -
US, UK reach deal on tariffs, market access
The deal includes a reduced tariff for some U.K. automobiles and is the first the Trump administration has secured after unveiling its reciprocal tariff plan in April.
By Philip Neuffer • May 8, 2025 -
Masimo says cyberattack has impacted its ability to fulfill orders
The maker of patient monitoring devices is working to bring the affected portions of its network back online and restore normal business operations.
By David Jones • May 8, 2025 -
Earnings & Tariffs
Siemens Healthineers lowers earnings forecast on expected tariff hit
The company expects a tariff impact of up to 300 million euros, with the biggest hit from European goods going to the U.S.
By Nick Paul Taylor • May 8, 2025 -
Masimo finds buyer for consumer audio business
In addition to offloading the Sound United segment for $350 million, the company lowered its 2025 profit forecast to account for tariffs.
By Susan Kelly • May 7, 2025 -
AdvaMed calls for ‘zero for zero’ medtech tariffs between US and UK
AdvaMed and its British counterpart called for urgent action to ensure the situation “does not devolve into a crisis.”
By Nick Paul Taylor • May 7, 2025 -
HHS overhaul
RFK’s FDA layoffs could slow safety communications, experts warn
The mass cuts, which included communications staff, could slow public notices on medical device recalls and other safety alerts.
By Elise Reuter • May 6, 2025 -
US semiconductor import probe looms over medtech industry
Medical device manufacturers could face increased costs if the Commerce Department's Section 232 probe leads to tariffs on chips.
By Susan Kelly • May 6, 2025 -
Earnings & Tariffs
Philips cuts earnings forecast after calculating $340M tariff hit
CEO Roy Jakobs said tariff impacts require the company to accelerate localization of production in the U.S.
By Nick Paul Taylor • May 6, 2025 -
Earnings & Tariffs
Zimmer Biomet expects $60M to $80M tariff impact this year
The orthopedics company lowered its earnings forecast, accounting for the tariffs and closing the acquisition of Paragon 28.
By Elise Reuter • May 6, 2025 -
Edwards gains expanded TAVR label for asymptomatic patients
The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement business with more patients becoming eligible for the treatment.
By Susan Kelly • May 5, 2025 -
Tracker
Trump policies are upending healthcare. Track the effect on the medtech industry here.
Policies and actions reshaping the healthcare industry began pouring out of President Donald Trump’s White House nearly from day one. Follow the changes affecting the medical device industry.
By MedTech Dive Staff • May 5, 2025 -
Earnings & Tariffs
Stryker expects $200M tariff hit, lowers earnings forecast
CEO Kevin Lobo said that without the tariffs, the company would have “raised our earnings without question.”
By Elise Reuter • May 2, 2025 -
News roundup
Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility
Intuitive secured a single port robot clearance, Resmed bought sleep testing facility Virtuox, and Precision Neuroscience hired an executive to support its BCI commercialization plans.
By Nick Paul Taylor • May 2, 2025 -
Abbott integrates diabetes data into Epic’s electronic health records
Linking the systems will allow clinicians to view glucose data captured by Libre glucose sensors within Epic’s systems.
By Nick Paul Taylor • May 1, 2025 -
Earnings & Tariffs
GE Healthcare slashes 2025 profit forecast on tariff impact
The full-year tariff impact of 85 cents per share would have more than doubled without mitigation actions underway, executives said on the earnings call.
By Susan Kelly • April 30, 2025 -
Senators call for investigation into BCI privacy
In a letter to the FTC, three Democratic senators called for privacy standards for brain computer interface technology.
By Elise Reuter • Updated April 30, 2025 -
Medtronic wins FDA approval for defibrillation lead
Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, according to Medtronic.
By Nick Paul Taylor • Updated May 5, 2025